Ventricular Assist Devices Market Size

  • Report ID: 1410
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Ventricular Assist Devices Market Size

Ventricular Assist Devices Market size was valued at USD 2.77 billion in 2024 and is poised to cross USD 8.96 billion by the end of 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of ventricular assist devices is estimated at USD 2.98 billion. The growth of the market can primarily be attributed to the growing prevalence of cardiovascular diseases, rapid globalization, and the increasing adoption of unhealthy lifestyles in developing countries. Based on the data provided by the World Health Organization (WHO), cardiovascular diseases were stated to be accounting for nearly 17.9 death in 2019 across the globe.

Global ventricular assist devices market trends such as the mounting prevalence of congenital heart disease and ongoing technological advancement in medical equipment along with a significant increment in global healthcare expenditure are projected to influence the growth of the market positively over the forecast period. It has been observed that congenital heart disease (CHDs) affects approximately 38,000 births every year solely in the USA. Moreover, ventricular assist devices (VAD) are mechanical circulatory support devices that provide assistance to pump blood from the lower chamber of the heart to the rest of the body. The demand for these devices is up surged by the rising awareness of the early diagnosis of heart diseases. Hence, all these factors are estimated to propel the growth of the market over the forecast period.


Ventricular Assist Devices Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 1410
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ventricular assist devices is estimated at USD 2.98 billion.

The ventricular assist devices market size was valued at USD 2.77 billion in 2024 and is poised to cross USD 8.96 billion by the end of 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. Rising penetration of stroke and increasing prevalence of coronary artery disease will drive the market growth.

North America industry is predicted to hold largest revenue share by 2037, driven by increasing cases of cardiac arrests along with rising adoption of new technological devices, and growing agreements for collaborations and development by the key players in the region.

The major players in the market include Abbott Laboratories, Sun Medical Technology Research Corpï¼Å½, Berlin Heart GmbH, Abiomed, Inc., ReliantHeart, Inc., Jarvik Heart, Inc, LivaNova, Inc., Boston Scientific Corporation, Calon cardio-Technology Ltd., Medtronic plc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample